Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines

KLAASSEN, U ; HARSTRICK, A ; SCHLEUCHER, N ; VANHOEFER, U ; SCHRÖDER, J ; WILKE, H ; SEEBER, S

British journal of cancer, 1996-07, Vol.74 (2), p.224-228 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível